Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bret R Rutherford

Showing results (31-40 of 84) with videos related to

Pageof 9
Sort By:
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|November 9, 2013
Clinic visits in late-life depression trials: effects on signal detection and therapeutic outcomeBret R Rutherford, Jane Tandler, Patrick J Brown, et al.
Journal of the American Psychoanalytic Association|May 15, 2012
Will patients accept randomization to psychoanalysis? A feasibility studyEve Caligor, Mark J Hilsenroth, Michael Devlin, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|December 21, 2016
Biological Aging and the Future of Geriatric PsychiatryBret R Rutherford, Warren D Taylor, Patrick J Brown, et al.
International Journal of Geriatric Psychiatry|October 15, 2013
The nuances of cognition and depression in older adults: the need for a comprehensive assessmentPatrick J Brown, Joel R Sneed, Bret R Rutherford, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 29, 2024
Retraction Note: Association between neuromelanin-sensitive MRI signal and psychomotor slowing in late-life depressionKenneth Wengler, Brandon K Ashinoff, Elena Pueraro, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 12, 2020
Association between neuromelanin-sensitive MRI signal and psychomotor slowing in late-life depressionKenneth Wengler, Brandon K Ashinoff, Elena Pueraro, et al.
Frontiers in Psychiatry|August 2, 2021
Cortical Thickness and Hippocampal Volume in Vascular and Non-vascular Depressed PatientsDakota A Egglefield, Sophie Schiff, Jeffrey N Motter, et al.
Journal of Clinical Psychopharmacology|June 29, 2021
Trajectories of Function and Symptom Change in Desvenlafaxine Clinical Trials: Toward Personalized Treatment for DepressionSigal Zilcha-Mano, Xuemei Wang, Dalia B Wajsbrot, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|November 14, 2007
Design makes a difference: a meta-analysis of antidepressant response rates in placebo-controlled versus comparator trials in late-life depressionJoel R Sneed, Bret R Rutherford, David Rindskopf, et al.
Translational Psychiatry|October 4, 2022
Correction to: Who benefits most from expectancy effects? A combined neuroimaging and antidepressant trial in depressed older adultsSigal Zilcha-Mano, Meredith L Wallace, Patrick J Brown, et al.
Pageof 9

Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|November 9, 2013
Clinic visits in late-life depression trials: effects on signal detection and therapeutic outcomeBret R Rutherford, Jane Tandler, Patrick J Brown, et al.
Journal of the American Psychoanalytic Association|May 15, 2012
Will patients accept randomization to psychoanalysis? A feasibility studyEve Caligor, Mark J Hilsenroth, Michael Devlin, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|December 21, 2016
Biological Aging and the Future of Geriatric PsychiatryBret R Rutherford, Warren D Taylor, Patrick J Brown, et al.
International Journal of Geriatric Psychiatry|October 15, 2013
The nuances of cognition and depression in older adults: the need for a comprehensive assessmentPatrick J Brown, Joel R Sneed, Bret R Rutherford, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 29, 2024
Retraction Note: Association between neuromelanin-sensitive MRI signal and psychomotor slowing in late-life depressionKenneth Wengler, Brandon K Ashinoff, Elena Pueraro, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 12, 2020
Association between neuromelanin-sensitive MRI signal and psychomotor slowing in late-life depressionKenneth Wengler, Brandon K Ashinoff, Elena Pueraro, et al.
Frontiers in Psychiatry|August 2, 2021
Cortical Thickness and Hippocampal Volume in Vascular and Non-vascular Depressed PatientsDakota A Egglefield, Sophie Schiff, Jeffrey N Motter, et al.
Journal of Clinical Psychopharmacology|June 29, 2021
Trajectories of Function and Symptom Change in Desvenlafaxine Clinical Trials: Toward Personalized Treatment for DepressionSigal Zilcha-Mano, Xuemei Wang, Dalia B Wajsbrot, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|November 14, 2007
Design makes a difference: a meta-analysis of antidepressant response rates in placebo-controlled versus comparator trials in late-life depressionJoel R Sneed, Bret R Rutherford, David Rindskopf, et al.
Translational Psychiatry|October 4, 2022
Correction to: Who benefits most from expectancy effects? A combined neuroimaging and antidepressant trial in depressed older adultsSigal Zilcha-Mano, Meredith L Wallace, Patrick J Brown, et al.
Pageof 9